Scolaris Content Display Scolaris Content Display

THF: Tetra Hydro Folate 
 Met: Methionine 
 SAMe: S‐Adenosylmethionine 
 PC: Phosphatidyl Choline 
 PE: Phosphatidyl Ethanolamine
Figuras y tablas -
Figure 1

THF: Tetra Hydro Folate
Met: Methionine
SAMe: S‐Adenosylmethionine
PC: Phosphatidyl Choline
PE: Phosphatidyl Ethanolamine

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 1 Mini Mental State Examination MMSE (changes from baseline at week 24).
Figuras y tablas -
Analysis 1.1

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 1 Mini Mental State Examination MMSE (changes from baseline at week 24).

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 2 DDST ( changes from baseline at week 24).
Figuras y tablas -
Analysis 1.2

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 2 DDST ( changes from baseline at week 24).

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 3 IADL ( changes from baseline at week 24).
Figuras y tablas -
Analysis 1.3

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 3 IADL ( changes from baseline at week 24).

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 4 SB ( changes from baseline at week 24).
Figuras y tablas -
Analysis 1.4

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 4 SB ( changes from baseline at week 24).

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 5 IADL/SB ( changes from baseline at week 24).
Figuras y tablas -
Analysis 1.5

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 5 IADL/SB ( changes from baseline at week 24).

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 6 Completers.
Figuras y tablas -
Analysis 1.6

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 6 Completers.

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 7 Treatment responders.
Figuras y tablas -
Analysis 1.7

Comparison 1 Folic acid (1mg/day) vs placebo for cognitive impairment, Outcome 7 Treatment responders.

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 1 Randt Memory Test ‐ acquisition and recall (change from baseline at 9 weeks).
Figuras y tablas -
Analysis 3.1

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 1 Randt Memory Test ‐ acquisition and recall (change from baseline at 9 weeks).

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 2 Randt Memory Test ‐ delayed recall (change from baseline at 9 weeks).
Figuras y tablas -
Analysis 3.2

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 2 Randt Memory Test ‐ delayed recall (change from baseline at 9 weeks).

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 3 Randt Memory Test ‐ memory index (change from baseline at 9 weeks).
Figuras y tablas -
Analysis 3.3

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 3 Randt Memory Test ‐ memory index (change from baseline at 9 weeks).

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 4 Randt Memory Test ‐ encoding (change from baseline at 9 weeks).
Figuras y tablas -
Analysis 3.4

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 4 Randt Memory Test ‐ encoding (change from baseline at 9 weeks).

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 5 Randt Memory Test ‐ cognitive efficiency (change from baseline at 9 weeks).
Figuras y tablas -
Analysis 3.5

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 5 Randt Memory Test ‐ cognitive efficiency (change from baseline at 9 weeks).

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 6 Randt Memory Test ‐ attention efficiency (change from baseline at 9 weeks).
Figuras y tablas -
Analysis 3.6

Comparison 3 Folic acid (15mg/day) vs placebo for cognitive impairment, Outcome 6 Randt Memory Test ‐ attention efficiency (change from baseline at 9 weeks).

Comparison 4 Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia, Outcome 1 MMSE (change from baseline at 12 weeks).
Figuras y tablas -
Analysis 4.1

Comparison 4 Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia, Outcome 1 MMSE (change from baseline at 12 weeks).

Comparison 4 Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia, Outcome 2 ADAS‐Cog (change from baseline at 12 weeks).
Figuras y tablas -
Analysis 4.2

Comparison 4 Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia, Outcome 2 ADAS‐Cog (change from baseline at 12 weeks).

Comparison 4 Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia, Outcome 3 BADL (change from baseline at 12 weeks).
Figuras y tablas -
Analysis 4.3

Comparison 4 Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia, Outcome 3 BADL (change from baseline at 12 weeks).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 1 Constuction complex figure of Rey ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.1

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 1 Constuction complex figure of Rey ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 2 Attention digit span forward ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.2

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 2 Attention digit span forward ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 3 Sensomotor speed motor planning ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.3

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 3 Sensomotor speed motor planning ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 4 Sensomotor speed, finger tapping ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.4

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 4 Sensomotor speed, finger tapping ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 5 Sensomotor speed trial making test (change from baseline at week 24).
Figuras y tablas -
Analysis 5.5

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 5 Sensomotor speed trial making test (change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 6 Memory 15 words learning, immediate recall ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.6

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 6 Memory 15 words learning, immediate recall ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 7 Memory, delayed recall (change from baseline at week 24).
Figuras y tablas -
Analysis 5.7

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 7 Memory, delayed recall (change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 8 Memory 15 learning word, recognition ( change from baseline at week 24 ).
Figuras y tablas -
Analysis 5.8

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 8 Memory 15 learning word, recognition ( change from baseline at week 24 ).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 9 Memory, complex figure of Rey, immediate recall ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.9

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 9 Memory, complex figure of Rey, immediate recall ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 10 Memory, complex figure of Rey, delayed recall ( change from baseline at week 24 ).
Figuras y tablas -
Analysis 5.10

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 10 Memory, complex figure of Rey, delayed recall ( change from baseline at week 24 ).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 11 Memory, digit span backward (change from baseline at week 24).
Figuras y tablas -
Analysis 5.11

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 11 Memory, digit span backward (change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 12 Executive function, motor planing ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.12

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 12 Executive function, motor planing ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 13 Excutive function, trial making test ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.13

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 13 Excutive function, trial making test ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 14 Excutive function, stroop test ( change from baseline at week 24).
Figuras y tablas -
Analysis 5.14

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 14 Excutive function, stroop test ( change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 15 Excutive function , similarities (change from baseline at week 24).
Figuras y tablas -
Analysis 5.15

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 15 Excutive function , similarities (change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 16 Excutive function, Raven (change from baseline at week 24).
Figuras y tablas -
Analysis 5.16

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 16 Excutive function, Raven (change from baseline at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 17 Executive function, word fluency, animals, numbers of nouns (changes from baselien at week 24).
Figuras y tablas -
Analysis 5.17

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 17 Executive function, word fluency, animals, numbers of nouns (changes from baselien at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 18 Executive function, word fluency, letters, numbers of nouns (changes from baselien at week 24).
Figuras y tablas -
Analysis 5.18

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 18 Executive function, word fluency, letters, numbers of nouns (changes from baselien at week 24).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 19 Homocysteine (mcmo/L) (changes from baseline at week 12).
Figuras y tablas -
Analysis 5.19

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 19 Homocysteine (mcmo/L) (changes from baseline at week 12).

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 20 Homocysteine (mcmol/L) (change from baseline at week 24).
Figuras y tablas -
Analysis 5.20

Comparison 5 Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency, Outcome 20 Homocysteine (mcmol/L) (change from baseline at week 24).

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 1 Global cognitive function (changes from baseline to 3‐year).
Figuras y tablas -
Analysis 6.1

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 1 Global cognitive function (changes from baseline to 3‐year).

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 2 Memory (change from baseline to 3‐year).
Figuras y tablas -
Analysis 6.2

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 2 Memory (change from baseline to 3‐year).

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 3 Sensorimotor speed (change from baseline at 3‐year).
Figuras y tablas -
Analysis 6.3

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 3 Sensorimotor speed (change from baseline at 3‐year).

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 4 Complex speed (change from baseline at 3‐year).
Figuras y tablas -
Analysis 6.4

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 4 Complex speed (change from baseline at 3‐year).

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 5 Information processing (change from baseline at 3‐year).
Figuras y tablas -
Analysis 6.5

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 5 Information processing (change from baseline at 3‐year).

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 6 Word fluency (change from baseline at 3‐year).
Figuras y tablas -
Analysis 6.6

Comparison 6 Folic acid (800 mcg/day) vs placebo in healthy elderly, Outcome 6 Word fluency (change from baseline at 3‐year).

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 1 Cognitive processing (change from baseline at 5 weeks).
Figuras y tablas -
Analysis 7.1

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 1 Cognitive processing (change from baseline at 5 weeks).

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 2 Memory (change from baseline at 5 weeks).
Figuras y tablas -
Analysis 7.2

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 2 Memory (change from baseline at 5 weeks).

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 3 Executive function (change from baseline at 5 weeks).
Figuras y tablas -
Analysis 7.3

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 3 Executive function (change from baseline at 5 weeks).

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 4 Verbal ability (change from baseline at 5 weeks).
Figuras y tablas -
Analysis 7.4

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 4 Verbal ability (change from baseline at 5 weeks).

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 5 Mood Measures (change from baseline at 5 weeks).
Figuras y tablas -
Analysis 7.5

Comparison 7 Folic acid (0.75 mg/day) vs placebo in healthy older women, Outcome 5 Mood Measures (change from baseline at 5 weeks).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 1 Four‐Choice Reaction Time (FCRT) fixed correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.1

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 1 Four‐Choice Reaction Time (FCRT) fixed correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 2 Four‐Choice Reaction Time (FCRT) fixed incorrect (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.2

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 2 Four‐Choice Reaction Time (FCRT) fixed incorrect (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 3 Four‐Choice Reaction Time (FCRT) fixed reaction time (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.3

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 3 Four‐Choice Reaction Time (FCRT) fixed reaction time (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 4 Four‐Choice Reaction Time (FCRT) random correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.4

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 4 Four‐Choice Reaction Time (FCRT) random correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 5 Four‐Choice Reaction Time (FCRT) random incorrect (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.5

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 5 Four‐Choice Reaction Time (FCRT) random incorrect (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 6 Four‐Choice Reaction Time (FCRT) random reaction time (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.6

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 6 Four‐Choice Reaction Time (FCRT) random reaction time (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 7 Four‐Choice Reaction Time (FCRT) transform correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.7

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 7 Four‐Choice Reaction Time (FCRT) transform correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 8 Four‐Choice Reaction Time (FCRT) transform reaction time (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.8

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 8 Four‐Choice Reaction Time (FCRT) transform reaction time (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 9 Four‐Choice Reaction Time (FCRT) transform incorrect (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.9

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 9 Four‐Choice Reaction Time (FCRT) transform incorrect (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 10 Continuous Attention Test (CAT) correct ( changes from baseline at week 4).
Figuras y tablas -
Analysis 8.10

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 10 Continuous Attention Test (CAT) correct ( changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 11 Countinous Attention Test (CAT) incorrect ( changes from baseline at week 4).
Figuras y tablas -
Analysis 8.11

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 11 Countinous Attention Test (CAT) incorrect ( changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 12 Countinous Attention Test (CAT) error index (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.12

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 12 Countinous Attention Test (CAT) error index (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 13 Digit‐symbol substitution (DSS) correct (change from baseline at week 4).
Figuras y tablas -
Analysis 8.13

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 13 Digit‐symbol substitution (DSS) correct (change from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 14 Digit‐symbol substitution (DSS) reaction time correct (change from baseline at week 4).
Figuras y tablas -
Analysis 8.14

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 14 Digit‐symbol substitution (DSS) reaction time correct (change from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 15 Digit‐symbol substitution (DSS) incorrect (change from baseline at week 4).
Figuras y tablas -
Analysis 8.15

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 15 Digit‐symbol substitution (DSS) incorrect (change from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 16 Scanning Memory Sets (SMS) three digits correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.16

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 16 Scanning Memory Sets (SMS) three digits correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 17 Scanning Memory Sets (SMS) three digits reaction time correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.17

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 17 Scanning Memory Sets (SMS) three digits reaction time correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 18 Scanning Memory Sets (SMS) four digits correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.18

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 18 Scanning Memory Sets (SMS) four digits correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 19 Scanning Memory Sets (SMS) four digits reaction time (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.19

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 19 Scanning Memory Sets (SMS) four digits reaction time (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 20 Scanning Memory Sets (SMS) five digits correct (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.20

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 20 Scanning Memory Sets (SMS) five digits correct (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 21 Scanning Memory Sets (SMS) five digits reaction time (changes from baseline at week 4).
Figuras y tablas -
Analysis 8.21

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 21 Scanning Memory Sets (SMS) five digits reaction time (changes from baseline at week 4).

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 22 Homocysteine level mcom/L (change from baseline at week 4).
Figuras y tablas -
Analysis 8.22

Comparison 8 Folic acid (5 mg/day) vs placebo in healthy elderly, Outcome 22 Homocysteine level mcom/L (change from baseline at week 4).

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 1 Memory, immediate recall.
Figuras y tablas -
Analysis 9.1

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 1 Memory, immediate recall.

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 2 Memory, delayed recall.
Figuras y tablas -
Analysis 9.2

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 2 Memory, delayed recall.

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 3 Memory, word recognition.
Figuras y tablas -
Analysis 9.3

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 3 Memory, word recognition.

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 4 Verbal ability.
Figuras y tablas -
Analysis 9.4

Comparison 9 Folic acid with or without vitamin B12 in healthy people, Outcome 4 Verbal ability.

Comparison 10 Folic acid with or without vitamin B12 for cognitive impairment and dementia, Outcome 1 MMSE.
Figuras y tablas -
Analysis 10.1

Comparison 10 Folic acid with or without vitamin B12 for cognitive impairment and dementia, Outcome 1 MMSE.

Table 1. Baseline characteristics of included studies

Study

Participant number

Age range

Females proportion

Diagnosis

MMSE range

ADAS‐Cog range

Homocysteine levels

Folic acid levels

Bryan 2002

40

65‐92

100%

healthy

Not assessed

Not assessed

Not assessed

Not assessed

Connelly 2008

41

Mean 76.27 (SD = 6.23)

29%

AD patients

Mean 23.49 (SD = 3.53)

Not assessed

Mean 18.39 (SD = 4.62)

Not assessed

Durga 2007

818

50‐70

28%

healthy

28‐30

Not assessed

13.0 (11.2‐14.7) µmol/L

12 (10‐15) nmol/L

Eussen 2006

195

>70

76%

healthy, with vitamin B12 deficiency

Mean 26.7± 3

Not assessed

15.3 ± 5.5 µmol/L

RBC 616 ± 218 nmol/L

Fioravanti 1997

39

70‐90

83%

mild to moderate cognitive impairment, not demented with folic acid <3 ng/ml

16‐24

Not assessed

Not assessed

Blood folate 2.28 (0.6) ng/ml

Pathansali 2006

24

73 (5.6)

87%

healthy

<27

Not assessed

11.2±2 µmol/L

6.3 ± 2.5 µmol/

Sommer 1998

11

76.7±4.1

15%

Demented

16‐27

Not assessed

Not assessed

127‐452 mcg/L (RBC)

VITAL 2003

149

56‐89

not reported

84 AD,11 mixed dementia, 47 MCI, 4 unclassified

10‐26

5‐55

5.7‐130.2 µmol/ (range)

1.7‐30.5 nmol/l (range)

Figuras y tablas -
Table 1. Baseline characteristics of included studies
Comparison 1. Folic acid (1mg/day) vs placebo for cognitive impairment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mini Mental State Examination MMSE (changes from baseline at week 24) Show forest plot

1

41

Mean Difference (IV, Fixed, 95% CI)

‐0.13 [‐1.96, 1.70]

2 DDST ( changes from baseline at week 24) Show forest plot

1

41

Mean Difference (IV, Fixed, 95% CI)

0.26 [‐4.12, 4.64]

3 IADL ( changes from baseline at week 24) Show forest plot

1

41

Mean Difference (IV, Fixed, 95% CI)

2.67 [0.25, 5.09]

4 SB ( changes from baseline at week 24) Show forest plot

1

41

Mean Difference (IV, Fixed, 95% CI)

1.38 [‐1.13, 3.89]

5 IADL/SB ( changes from baseline at week 24) Show forest plot

1

41

Mean Difference (IV, Fixed, 95% CI)

4.01 [0.50, 7.52]

6 Completers Show forest plot

1

49

Odds Ratio (M‐H, Fixed, 95% CI)

0.10 [0.01, 1.91]

7 Treatment responders Show forest plot

1

49

Odds Ratio (M‐H, Fixed, 95% CI)

4.06 [1.22, 13.53]

Figuras y tablas -
Comparison 1. Folic acid (1mg/day) vs placebo for cognitive impairment
Comparison 2. Folic acid (10mg/day) vs placebo for cognitive impairment and dementia

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Language: WAIS‐R:Pro‐rated Verbal IQ (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Boston Naming Test (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Controlled Oral Word Association Test (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

4 WMS:Logical Memory Subtest (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

5 WMS: Associated Learning Subtest (changes from baseline at week 10 )

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

6 Speed/Concentration:Trial A (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

7 Speed/Concentration: Trial B (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Fingger Tapping Test (changes from baseline at week 10)

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 2. Folic acid (10mg/day) vs placebo for cognitive impairment and dementia
Comparison 3. Folic acid (15mg/day) vs placebo for cognitive impairment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Randt Memory Test ‐ acquisition and recall (change from baseline at 9 weeks) Show forest plot

1

29

Mean Difference (IV, Fixed, 95% CI)

5.47 [‐10.05, 20.99]

2 Randt Memory Test ‐ delayed recall (change from baseline at 9 weeks) Show forest plot

1

29

Mean Difference (IV, Fixed, 95% CI)

7.38 [‐8.58, 23.34]

3 Randt Memory Test ‐ memory index (change from baseline at 9 weeks) Show forest plot

1

29

Mean Difference (IV, Fixed, 95% CI)

7.34 [‐9.67, 24.35]

4 Randt Memory Test ‐ encoding (change from baseline at 9 weeks) Show forest plot

1

29

Mean Difference (IV, Fixed, 95% CI)

0.67 [‐1.89, 3.23]

5 Randt Memory Test ‐ cognitive efficiency (change from baseline at 9 weeks) Show forest plot

1

29

Mean Difference (IV, Fixed, 95% CI)

0.57 [‐1.97, 3.11]

6 Randt Memory Test ‐ attention efficiency (change from baseline at 9 weeks) Show forest plot

1

29

Mean Difference (IV, Fixed, 95% CI)

1.05 [‐0.17, 2.27]

Figuras y tablas -
Comparison 3. Folic acid (15mg/day) vs placebo for cognitive impairment
Comparison 4. Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 MMSE (change from baseline at 12 weeks) Show forest plot

1

138

Mean Difference (IV, Fixed, 95% CI)

0.39 [‐0.43, 1.21]

2 ADAS‐Cog (change from baseline at 12 weeks) Show forest plot

1

133

Mean Difference (IV, Fixed, 95% CI)

0.41 [‐1.25, 2.07]

3 BADL (change from baseline at 12 weeks) Show forest plot

1

134

Mean Difference (IV, Fixed, 95% CI)

‐0.57 [‐1.95, 0.81]

Figuras y tablas -
Comparison 4. Folic acid (2 mg/day) + vitamin B12 (1mg/day) for mild cognitive impairment or dementia
Comparison 5. Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Constuction complex figure of Rey ( change from baseline at week 24) Show forest plot

1

97

Mean Difference (IV, Fixed, 95% CI)

‐0.5 [‐5.33, 4.33]

2 Attention digit span forward ( change from baseline at week 24) Show forest plot

1

107

Mean Difference (IV, Fixed, 95% CI)

‐0.30 [‐1.17, 0.57]

3 Sensomotor speed motor planning ( change from baseline at week 24) Show forest plot

1

94

Mean Difference (IV, Fixed, 95% CI)

84.0 [‐80.38, 248.38]

4 Sensomotor speed, finger tapping ( change from baseline at week 24) Show forest plot

1

94

Mean Difference (IV, Fixed, 95% CI)

3.0 [‐119.50, 125.50]

5 Sensomotor speed trial making test (change from baseline at week 24) Show forest plot

1

104

Mean Difference (IV, Fixed, 95% CI)

‐9.0 [‐34.41, 16.41]

6 Memory 15 words learning, immediate recall ( change from baseline at week 24) Show forest plot

1

106

Mean Difference (IV, Fixed, 95% CI)

0.5 [‐5.25, 6.25]

7 Memory, delayed recall (change from baseline at week 24) Show forest plot

1

105

Mean Difference (IV, Fixed, 95% CI)

0.60 [‐1.42, 2.62]

8 Memory 15 learning word, recognition ( change from baseline at week 24 ) Show forest plot

1

105

Mean Difference (IV, Fixed, 95% CI)

‐0.90 [‐2.87, 1.07]

9 Memory, complex figure of Rey, immediate recall ( change from baseline at week 24) Show forest plot

1

95

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐3.92, 4.32]

10 Memory, complex figure of Rey, delayed recall ( change from baseline at week 24 ) Show forest plot

1

92

Mean Difference (IV, Fixed, 95% CI)

‐0.5 [‐4.60, 3.60]

11 Memory, digit span backward (change from baseline at week 24) Show forest plot

1

107

Mean Difference (IV, Fixed, 95% CI)

‐0.8 [‐1.62, 0.02]

12 Executive function, motor planing ( change from baseline at week 24) Show forest plot

1

92

Mean Difference (IV, Fixed, 95% CI)

35.0 [‐247.33, 317.33]

13 Excutive function, trial making test ( change from baseline at week 24) Show forest plot

1

100

Mean Difference (IV, Fixed, 95% CI)

0.5 [‐0.20, 1.20]

14 Excutive function, stroop test ( change from baseline at week 24) Show forest plot

1

97

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

15 Excutive function , similarities (change from baseline at week 24) Show forest plot

1

106

Mean Difference (IV, Fixed, 95% CI)

0.50 [‐1.02, 2.02]

16 Excutive function, Raven (change from baseline at week 24) Show forest plot

1

103

Mean Difference (IV, Fixed, 95% CI)

0.5 [‐1.55, 2.55]

17 Executive function, word fluency, animals, numbers of nouns (changes from baselien at week 24) Show forest plot

1

106

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐3.55, 2.35]

18 Executive function, word fluency, letters, numbers of nouns (changes from baselien at week 24) Show forest plot

1

105

Mean Difference (IV, Fixed, 95% CI)

‐1.80 [‐5.91, 2.31]

19 Homocysteine (mcmo/L) (changes from baseline at week 12) Show forest plot

1

103

Mean Difference (IV, Fixed, 95% CI)

‐4.5 [‐7.05, ‐1.95]

20 Homocysteine (mcmol/L) (change from baseline at week 24) Show forest plot

1

105

Mean Difference (IV, Fixed, 95% CI)

‐5.90 [‐8.43, ‐3.37]

Figuras y tablas -
Comparison 5. Folic acid( 400 mcg/day) + vitamin B12 (1000 mcg/day) in healthy elderly with mild B12 deficiency
Comparison 6. Folic acid (800 mcg/day) vs placebo in healthy elderly

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Global cognitive function (changes from baseline to 3‐year) Show forest plot

1

818

Mean Difference (IV, Fixed, 95% CI)

0.05 [0.00, 0.10]

2 Memory (change from baseline to 3‐year) Show forest plot

1

818

Mean Difference (IV, Fixed, 95% CI)

0.14 [0.04, 0.24]

3 Sensorimotor speed (change from baseline at 3‐year) Show forest plot

1

818

Mean Difference (IV, Fixed, 95% CI)

0.06 [‐0.00, 0.12]

4 Complex speed (change from baseline at 3‐year) Show forest plot

1

818

Mean Difference (IV, Fixed, 95% CI)

0.04 [‐0.05, 0.13]

5 Information processing (change from baseline at 3‐year) Show forest plot

1

818

Mean Difference (IV, Fixed, 95% CI)

0.09 [0.02, 0.16]

6 Word fluency (change from baseline at 3‐year) Show forest plot

1

818

Mean Difference (IV, Fixed, 95% CI)

‐0.07 [‐0.19, 0.05]

Figuras y tablas -
Comparison 6. Folic acid (800 mcg/day) vs placebo in healthy elderly
Comparison 7. Folic acid (0.75 mg/day) vs placebo in healthy older women

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Cognitive processing (change from baseline at 5 weeks) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

1.1 Speed of processing ‐ boxes

1

39

Mean Difference (IV, Fixed, 95% CI)

2.12 [‐11.28, 15.52]

1.2 Speed of processing ‐ digit symbol coding

1

39

Mean Difference (IV, Fixed, 95% CI)

2.19 [‐7.40, 11.78]

1.3 Speed of processing ‐ symbol search

1

39

Mean Difference (IV, Fixed, 95% CI)

1.59 [‐1.55, 4.73]

1.4 Working memory ‐ digit span backwards

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.31 [‐2.66, 2.04]

1.5 Working memory ‐ letter number sequencing

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.5 [‐2.78, 1.78]

2 Memory (change from baseline at 5 weeks) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

2.1 Immediate recall ‐ RAVLT 1‐5

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐6.87, 6.75]

2.2 Immediate recall ‐ RAVLT B

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.54 [‐2.05, 0.97]

2.3 Delayed recall ‐ RAVLT 6

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.07 [‐2.28, 2.14]

2.4 Delayed recall ‐ RAVLT 7

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.34 [‐2.85, 2.17]

2.5 Recognition ‐ RAVLT A

1

39

Mean Difference (IV, Fixed, 95% CI)

1.42 [‐0.24, 3.08]

2.6 Recognition ‐ RAVLT B

1

39

Mean Difference (IV, Fixed, 95% CI)

1.59 [‐1.35, 4.53]

3 Executive function (change from baseline at 5 weeks) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

3.1 Stroop

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.09 [‐0.44, 0.26]

3.2 Trail making test : Test A

1

39

Mean Difference (IV, Fixed, 95% CI)

2.29 [‐11.40, 15.98]

3.3 Trail making test: Test B

1

39

Mean Difference (IV, Fixed, 95% CI)

‐5.21 [‐37.01, 26.59]

3.4 Verbal fluency ‐ initial letter

1

39

Mean Difference (IV, Fixed, 95% CI)

‐3.44 [‐11.20, 4.32]

3.5 Verbal fluency ‐ excluded letter

1

39

Mean Difference (IV, Fixed, 95% CI)

0.57 [‐6.76, 7.90]

4 Verbal ability (change from baseline at 5 weeks) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.1 Vocabulary

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.13 [‐4.87, 4.61]

4.2 Spot the word

1

39

Mean Difference (IV, Fixed, 95% CI)

0.87 [‐7.92, 9.66]

5 Mood Measures (change from baseline at 5 weeks) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

5.1 CESD ‐ depression

1

39

Mean Difference (IV, Fixed, 95% CI)

‐1.11 [‐7.31, 5.09]

5.2 POMS: total

1

39

Mean Difference (IV, Fixed, 95% CI)

‐3.14 [‐23.56, 17.28]

5.3 POMS ‐ Tension/anxiety

1

39

Mean Difference (IV, Fixed, 95% CI)

0.3 [‐3.93, 4.53]

5.4 POMS ‐ Depression/dejection

1

39

Mean Difference (IV, Fixed, 95% CI)

0.59 [‐5.45, 6.63]

5.5 POMS ‐ Anger/hostility

1

39

Mean Difference (IV, Fixed, 95% CI)

0.97 [‐3.29, 5.23]

5.6 POMS ‐ Vigour/activity

1

39

Mean Difference (IV, Fixed, 95% CI)

3.13 [‐2.26, 8.52]

5.7 POMS ‐ Fatigue/inertia

1

39

Mean Difference (IV, Fixed, 95% CI)

‐1.83 [‐5.85, 2.19]

5.8 POMS ‐ Confusion/bewilderment

1

39

Mean Difference (IV, Fixed, 95% CI)

‐0.05 [‐3.05, 2.95]

Figuras y tablas -
Comparison 7. Folic acid (0.75 mg/day) vs placebo in healthy older women
Comparison 8. Folic acid (5 mg/day) vs placebo in healthy elderly

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Four‐Choice Reaction Time (FCRT) fixed correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐6.0 [‐16.29, 4.29]

2 Four‐Choice Reaction Time (FCRT) fixed incorrect (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.0 [‐0.31, 0.31]

3 Four‐Choice Reaction Time (FCRT) fixed reaction time (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.03 [‐0.06, 0.12]

4 Four‐Choice Reaction Time (FCRT) random correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

6.75 [‐3.70, 17.20]

5 Four‐Choice Reaction Time (FCRT) random incorrect (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.75 [‐1.82, 0.32]

6 Four‐Choice Reaction Time (FCRT) random reaction time (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.02 [‐0.11, 0.07]

7 Four‐Choice Reaction Time (FCRT) transform correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Four‐Choice Reaction Time (FCRT) transform reaction time (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.08 [‐0.15, 0.31]

9 Four‐Choice Reaction Time (FCRT) transform incorrect (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

10 Continuous Attention Test (CAT) correct ( changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

1.94 [1.00, 4.88]

11 Countinous Attention Test (CAT) incorrect ( changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.19 [‐1.55, 1.17]

12 Countinous Attention Test (CAT) error index (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.04 [‐0.11, 0.03]

13 Digit‐symbol substitution (DSS) correct (change from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.66 [‐0.49, 1.81]

14 Digit‐symbol substitution (DSS) reaction time correct (change from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.21 [0.01, 0.41]

15 Digit‐symbol substitution (DSS) incorrect (change from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.66 [‐1.81, 0.49]

16 Scanning Memory Sets (SMS) three digits correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.58 [‐1.60, 0.44]

17 Scanning Memory Sets (SMS) three digits reaction time correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.04 [‐0.05, 0.13]

18 Scanning Memory Sets (SMS) four digits correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.01 [‐1.69, 1.67]

19 Scanning Memory Sets (SMS) four digits reaction time (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐0.01 [‐0.14, 0.12]

20 Scanning Memory Sets (SMS) five digits correct (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.15 [‐1.97, 2.27]

21 Scanning Memory Sets (SMS) five digits reaction time (changes from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

0.0 [‐0.12, 0.12]

22 Homocysteine level mcom/L (change from baseline at week 4) Show forest plot

1

24

Mean Difference (IV, Fixed, 95% CI)

‐1.6 [‐4.28, 1.08]

Figuras y tablas -
Comparison 8. Folic acid (5 mg/day) vs placebo in healthy elderly
Comparison 9. Folic acid with or without vitamin B12 in healthy people

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Memory, immediate recall Show forest plot

2

145

Mean Difference (IV, Fixed, 95% CI)

0.27 [‐4.14, 4.67]

2 Memory, delayed recall Show forest plot

2

145

Mean Difference (IV, Fixed, 95% CI)

0.23 [‐1.34, 1.80]

3 Memory, word recognition Show forest plot

2

144

Mean Difference (IV, Fixed, 95% CI)

0.46 [‐0.81, 1.73]

4 Verbal ability Show forest plot

3

963

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐0.18, 0.06]

Figuras y tablas -
Comparison 9. Folic acid with or without vitamin B12 in healthy people
Comparison 10. Folic acid with or without vitamin B12 for cognitive impairment and dementia

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 MMSE Show forest plot

2

179

Mean Difference (IV, Fixed, 95% CI)

0.30 [‐0.45, 1.05]

Figuras y tablas -
Comparison 10. Folic acid with or without vitamin B12 for cognitive impairment and dementia